PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0011570|depression |
| Sentences | 56 |
| PubMedID- 24337537 | Whether effective treatment of depression improves survival in patients with breast cancer remains to be determined. |
| PubMedID- 25806355 | In addition, breast cancer patients with depression have typically been excluded from studies (5, 8, 17, 18, 20–24, 27, 31–36), or these factors were statistically controlled for (7, 26, 38). |
| PubMedID- 25954147 | (2013) investigated fatigue and depression symptoms in patients with breast cancer. |
| PubMedID- 20385344 | Although many studies on the treatment of depression in women with breast cancer have been done, and the data do point to the efficacy of several antidepressants in this population, there are no data to support the widely held hypothesis that treatment of depression in patients with breast cancer may positively affect morbidity and mortality. |
| PubMedID- 25761086 | Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean. |
| PubMedID- 23967823 | However, due to a few of studies (the number is less than or equal to 3) separately reporting the or for depression and anxiety in patients with breast cancer, lung cancer, liver cancer, the subgroup comparison of depression and anxiety in different types of cancer patients were not analyzed. |
| PubMedID- 23512358 | Radiation is an essential component of breast-conserving therapy and may contribute to depression in patients with breast cancer through the activation of inflammatory pathways. |
| PubMedID- 24243809 | Eysenck personality questionnaire revised psychoticism predicts motivational-somatic symptoms of depression in breast cancer survivors. |
| PubMedID- 23217093 | Methods/design: eligible breast cancer patients with comorbid depression are assigned to short-term psychodynamic psychotherapy (up to 20 + 5 sessions) or to treatment as usual (augmented by recommendation for counseling center and physician information). |
| PubMedID- 23731173 | Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients. |
| PubMedID- 22409643 | Anxiety and depression in breast cancer survivors of different sexual orientations. |
| PubMedID- 25377647 | Here, we review the prevalence and treatment of anxiety and depression among patients with breast cancer. |
| PubMedID- 19734087 | Anxiety, depression and quality of life among chinese breast cancer patients during adjuvant therapy. |
| PubMedID- 23646866 | Methods: sixty-two breast cancer patients diagnosed with major depression were randomly assigned to gcbt group (n = 31) or a waiting list control group provided with an educational booklet (n = 31). |
| PubMedID- 26497200 | Finally, anger suppression may play a unique role in predicting symptoms of depression in women with breast cancer. |
| PubMedID- 23865135 | Objective: to investigate the prevalence of depression in women with breast cancer and relate it to their health-related quality of life. |
| PubMedID- 26445699 | 1996), whereas a helplessness/hopelessness stress-coping style is associated with depression in patients with breast cancer (schou et al. |
| PubMedID- 24347520 | The purpose of this trial was to determine the efficacy of short-term psychodynamic psychotherapy (stpp) in non-metastatic breast cancer patients diagnosed with depression, one of the most frequent mental comorbidities of breast cancer. |
| PubMedID- 20602189 | A randomized trial of bupropion vs. other antidepressants, both at standard and lower doses (similar to those used for hot flash management), would provide valuable information and offer options for breast cancer patients with both depression and sexual dysfunction. |
| PubMedID- 25543421 | Efficacy on depression in breast cancer treated with acupuncture and auricular acupressure. |
| PubMedID- 26508964 | Taken together, these findings suggest that higher bdnf promoter methylation status may be a biological marker of depression in patients with breast cancer, at least at 1 week and 1 year after breast surgery. |
| PubMedID- 20142325 | The prevalence of depression in women with early breast cancer is roughly twice that of the general female population and is particularly high around the time of diagnosis.39 in our study, 30% of women who started tamoxifen treatment also received antidepressants, and paroxetine was the most commonly used ssri. |
| PubMedID- 26453348 | These results suggest that ipt is a promising treatment for depression in women with breast cancer. |
| PubMedID- 19458878 | Materials and methods: this was a prospective study of anxiety and depression in breast cancer patients. |
| PubMedID- 25788991 | In a cohort study investigating breast cancer outcomes in patients with depression, only 51% of the study group (breast cancer patients with depression) accepted and commenced chemotherapy, compared with 92% of the control group (breast cancer patients without depression) (4). |
| PubMedID- 24817896 | Arts therapies for anxiety, depression, and quality of life in breast cancer patients: a systematic review and meta-analysis. |
| PubMedID- 23604452 | Icf, quality of life, and depression in breast cancer: perceived disability in disease-free women 6 months after mastectomy. |
| PubMedID- 24362868 | Treatment of depression in patients with breast cancer: a critical review. |
| PubMedID- 21054923 | Sexual abuse in childhood and postoperative depression in women with breast cancer who opt for immediate reconstruction after mastectomy. |
| PubMedID- 24077731 | Further antidepressant studies are needed to guide depression treatment in patients with breast cancer. |
| PubMedID- 26009671 | Aim: to compare the effects of yoga program with supportive therapy on self-reported symptoms of depression in breast cancer patients undergoing conventional treatment. |
| PubMedID- 23346176 | The specific aims of the current study were to examine the unmet needs and depression among patients with recurrent breast cancer and to explore the predictive value of unmet needs on qol along with socio-demographic and clinical variables. |
| PubMedID- 25684491 | Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors. |
| PubMedID- 25780852 | Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy. |
| PubMedID- 22699176 | Further studies are needed to identify the effect on emotions such as anxiety and depression for women with breast cancer with above average levels of anxiety and depression. |
| PubMedID- 20446075 | Background: depression in breast cancer (bca) patients can reduce quality of life, relationships and treatment compliance, thus constituting a major target for cognitive behavioural (cbt) interventions. |
| PubMedID- 25960844 | Effectiveness of group training based on acceptance and commitment therapy on anxiety and depression of women with breast cancer. |
| PubMedID- 25287728 | Methods: seventy-seven breast cancer patients with comorbid depression were evaluated with the hamilton depression rating scale (hamd), the clinical global impression-severity of illness (cgi-s) for depression, and the functional assessment of cancer therapy-breast (fact-b). |
| PubMedID- 26035180 | breast cancer patients with a depression diagnosis also had lower mortality (or=0.69, 95% ci: 0.52-0.89) compared with those without a depression diagnosis, but there was no significant difference in mortality among those with and without anxiety diagnoses. |
| PubMedID- 20814770 | Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. |
| PubMedID- 22888085 | depression in breast cancer patients and survivors is related to negative disease outcomes and worse quality of life. |
| PubMedID- 23265707 | Purpose: to test the effect of such a programme on anxiety and depression among women with breast cancer in a population-based randomised controlled study. |
| PubMedID- 21462281 | Conclusion: our study suggests a high rate of associated depression among patients with breast cancer in our environment. |
| PubMedID- 25674442 | The use of selected serotonin reuptake inhibitors (ssri’s), anti-depressives used to treat both hot flashes and depression in women with breast cancer, has recently been the focus of controversy. |
| PubMedID- 23788906 | The association of breast cancer with anxiety and depression has been supported in previous studies . |
| PubMedID- 23725190 | Prevalence of depression in breast cancer survivors: a systematic review of observational studies. |
| PubMedID- 22639749 | In some studies, it has been stated that breast cancer metastasis is associated with depression and overall quality of life, and it has also been reported that the recurrence of breast cancer strongly lowered the quality of life of patients, and even their guardians.6,7 this appears to be due to a fear of additional metastasis as well as the burden of additional treatments after metastasis. |
| PubMedID- 23041586 | Conclusions: exercise intervention improved fatigue, depression, and qol in patients with breast cancer receiving adjuvant therapy. |
| PubMedID- 25921125 | Background: whether depression causes increased risk of the development of breast cancer has long been debated. |
| PubMedID- 26516588 | Now established agents such as trastuzumab (herceptin), a monoclonal antibody targeted against mutant forms of the her2/neu receptor licensed for use against some forms of breast cancer, are associated with cardiac depression and an increase in adverse outcomes when combined with other anticancer agents with known cardiotoxicity risks (seidman et al. |
Page: 1 2